Ronald Kiguba
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions 16
-
- Antibiotic Use and Resistance 6
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes 5
- Virology top 10%
- HIV Research and Treatment 6
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 9
- HIV/AIDS Research and Interventions 5
-
- Pharmaceutical studies and practices 9
-
- Pharmaceutical Economics and Policy 5
- Co-authors
- Sheila M. BirdCharles KaramagiSten OlssonCatriona WaittPaul WaakoElly KatabiraJayne Byakika-TusiimeFrancis Ssali
- Journals
- PLoS ONE (2 papers)Journal of Antimicrobial Chemotherapy (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- UgandaUnited KingdomUnited States
In The Last Decade
Ronald Kiguba
40 papers receiving 485 citations
Peers
Comparison fields: 5 of 84
- Toxicology 151
- Applied Microbiology and Biotechnology 66
- Geriatrics and Gerontology 69
- Virology 62
- Infectious Diseases 141
Countries citing papers authored by Ronald Kiguba
This map shows the geographic impact of Ronald Kiguba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Kiguba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Kiguba more than expected).
Fields of papers citing papers by Ronald Kiguba
This network shows the impact of papers produced by Ronald Kiguba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Kiguba. The network helps show where Ronald Kiguba may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ronald Kiguba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 10 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 9 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 4 | |
| 10 | 2020 | 2 | |
| 11 | 2017 | 33 | |
| 12 | 2017 | 15 | |
| 13 | 2015 | 12 | |
| 14 | 2015 | 4 | |
| 15 | 2014 | 34 | |
| 16 | 2013 | 9 | |
| 17 | Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting. | 2011 | 34 |
| 18 | 2011 | 9 | |
| 19 | 2010 | 3 | |
| 20 | 2007 | 41 |
About Ronald Kiguba
Ronald Kiguba is a scholar working on Toxicology, Applied Microbiology and Biotechnology and Geriatrics and Gerontology, having authored 41 papers that have together received 498 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (16 papers), HIV/AIDS drug development and treatment (9 papers), Pharmaceutical studies and practices (9 papers), HIV Research and Treatment (6 papers), Antibiotic Use and Resistance (6 papers), HIV/AIDS Research and Interventions (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Pharmaceutical Economics and Policy (5 papers). The work is most often cited by research in Toxicology (151 citations), Applied Microbiology and Biotechnology (66 citations) and Geriatrics and Gerontology (69 citations). Ronald Kiguba has collaborated with scholars based in Uganda, United Kingdom and United States. Frequent co-authors include Sheila M. Bird, Charles Karamagi, Sten Olsson, Catriona Waitt, Paul Waako, Elly Katabira, Charles Karamagi, Jayne Byakika-Tusiime, Francis Ssali and Peter Mugyenyi. Their work appears in journals such as PLoS ONE, Journal of Antimicrobial Chemotherapy and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.